Which<br/>oral drug for treating hyperglycemia can delay the absorption of<br/>carbohydrate and lower postprandial glycemic excursion: ( <br/>) A: Sulfonylureas B: Metformin C: Acarbose D: Insulin E: Thiazolidinediones
Which<br/>oral drug for treating hyperglycemia can delay the absorption of<br/>carbohydrate and lower postprandial glycemic excursion: ( <br/>) A: Sulfonylureas B: Metformin C: Acarbose D: Insulin E: Thiazolidinediones
2.If you don`t receive treatment for hyperglycemia ,in order to produce energy, your body turns to____ as an alternative source of energy. A: Fat and proteins B: Fat C: Proteins D: Lactose
2.If you don`t receive treatment for hyperglycemia ,in order to produce energy, your body turns to____ as an alternative source of energy. A: Fat and proteins B: Fat C: Proteins D: Lactose
Which<br/>oral drug for treating hyperglycemia can delay the absorption of<br/>carbohydrate and lower postprandial glycemic excursion: ____ A: sulfonylureas B: metformin C: acarbose D: insulin E: DPP-IV<br/>inhibitor
Which<br/>oral drug for treating hyperglycemia can delay the absorption of<br/>carbohydrate and lower postprandial glycemic excursion: ____ A: sulfonylureas B: metformin C: acarbose D: insulin E: DPP-IV<br/>inhibitor
Which of the Following is best describes clinical presentation of sign diabetes ketoacidosis (DKA) A: oliguria, ketonuria, abdominal pain B: Ketonuria, polydipsia, abdominal pain, Kussmaul breathing C: Ketonuria, abdominal pain, Kussmaul breathing with Fruity odour and Hyperglycemia D: Abdominal pain and high blood sugar.
Which of the Following is best describes clinical presentation of sign diabetes ketoacidosis (DKA) A: oliguria, ketonuria, abdominal pain B: Ketonuria, polydipsia, abdominal pain, Kussmaul breathing C: Ketonuria, abdominal pain, Kussmaul breathing with Fruity odour and Hyperglycemia D: Abdominal pain and high blood sugar.